Between Two Ventricles™ is a cardiology podcast series brought to you by Abbott. Join us as our host, Phil Adamson, MD, interviews leading specialists in the field of heart failure to discuss the most up to date innovations, products and clinical advancements for managing and treating heart failure.
In this episode, host Dr. Phil Adamson and Dr. Jennifer Cowger team up to discuss how healthcare providers may redefine their response toward advanced heart failure patients who could be considered for durable MCS. Dr. Cowger provides her approach to educating advanced heart failure patients on LVAD treatment, quality of life, functional capacity, and survival. Dr. Adamson and Dr. Cowger also discuss the importance of a collaborative care model with advanced heart failure providers, local cardiologists, and primary care team.
In this episode, Dr. Kelly Axsom, Assistant Professor of Medicine in the Division of Cardiology, Center for Advanced Cardiac Care of the Columbia University Medical Center, and the Medical Director of the New York-Presbyterian Hospital Centralized Heart Failure Management Program has a conversation with Dr. Phil Adamson. Dr. Axsom discusses how a centralized HF program and the use of remote monitoring devices, such as the CardioMEMS™ HF System, can help alleviate the burden of managing heart failure patients.
Drs. Axsom and Adamson also discuss how NYHA Classes make it hard to distinguish heart failure risk and that there needs to be a paradigm shift to use BNP as a marker for therapy to help catch patients sooner in their heart failure progression. In the field of heart failure, Dr. Axsom is seeing a shift to focus on preventative heart failure, enforcing that if you treat the condition, screen the pressures, and keep congestion down you can help a patient live their best life for longer.
In this episode, Kevin Bourque, Divisional Vice President of Product Development at Abbott, overseeing mechanical circulatory support (MCS) discusses his 25-year involvement in the design and development of Abbott’s HeartMate Left Ventricular Assist Systems. Kevin also discusses the landmark MOMENTUM 3 5-Year outcomes.
The MOMEMTUM 3 5-Year Outcomes demonstrate that median survival with the HeartMate 3™ LVAD reliably exceeds 5 years, even in those patients with refractory heart failure who are ineligible for transplantation.
In this episode, Dr. Jason Guichard of Prisma Health Greenville Memorial discusses receiving the coveted UNIVANTS of Healthcare Excellence award for enhancing personalized care for their heart failure patients after implementation of InView EMR™ Patient Identification and Workflows. This prestigious award recognizes teams who collaborate across disciplines to transform healthcare delivery and patient lives.
Leveraging capabilities inherent in the EMR, the team at Greenville Memorial implemented a patient identification workflow program powered by InView EMR to identify heart failure patients earlier, improve access to and utilization of limited resources and reduce the overall cost of care.1 InView EMR creates actionable, real-time, point of care workflows to drive patients to specific clinical providers and assesses both population level and individual patient health status.
Dr. Kunjan Bhatt discusses the GUIDE-HF Trial results, CardioMEMS HF System expanded indication, and the utilization of elevated BNP in identifying appropriate patients for remote hemodynamic management. The GUIDE-HF clinical trial results reaffirm and expand the reach of preventative heart failure management. As previously demonstrated, remote hemodynamic management of heart failure patients is directly attributed to a consistent reduction in pulmonary artery pressures and heart failure hospitalizations.
Philip B. Adamson, M.D., MSc, FACC, interviews Giles Peek, M.D., FRCS, CTh, FFICM to discuss the current state of VV-ECMO and future predictions of what may come in the field of extracorporeal membrane oxygenation. Dr. Peek has served as the director of the adult, pediatric and neonatal extracorporeal membrane oxygenation, or ECMO program, where he initiated the country's first and only pediatric mobile ECMO service. He also served as chief of pediatric cardiac surgery at the Children’s Hospital at Montefiore in New York. Dr. Peek’s research interest is in the use of ECMO for both cardiac and respiratory support for babies, children and adults.
In this episode, Dr. Sophia Airhart shares her experience as an up-and-coming advanced heart failure and pulmonary hypertension cardiologist, providing insight on mentorship, how to overcome obstacles and the various resources available for navigating the field.
In this episode Philip B. Adamson, MD, MSc, FACC, interviews Robert Buffington, a CardioMEMS HF System patient. Robert discusses his journey with heart failure and how the CardioMEMS HF System has impacted his life.
Joyce Wald, DO, FACC, discusses how a cross-functional collaborative team, with a patient-centered approach, can improve clinical outcomes of acute cardiogenic shock with the CentriMag™ Acute Circulatory Support System.
As one of the oldest occupations, nurses have faced and inspired an array of change. The most remarkable not only raised the profession but patient outcomes and the overall state of healthcare. Join us as Beth Davidson, DNP talks about how the nursing profession has evolved over the years with heart failure management.
With several implantable left ventricular assist devices (LVADs) being utilized in patients with advanced heart failure, the CLEAR-LVAD study aims to utilize real world data regarding survival outcomes and healthcare expenditures to provide comparisons across devices. Dr. Francis Pagani, Professor of Surgery and Director of the Heart Transplant Program and the Center for Circulatory Support at the University of Michigan Medical Center, will discuss the current state of LVAD therapy and how INTERMACS data can be utilized in clinical studies. Dr. Pagani will also review the findings of the CLEAR-LVAD study and how these results will impact the field of Mechanical Circulatory Support moving forward.
Kelly McCants, M.D., Medical Director of Advanced Heart Failure, and Executive Director of the Norton Healthcare Institute for Health Equity discusses how racial inequities in the management of heart failure patients can be identified and combated. Strategies for improving access to advanced therapies are also discussed.
William Jakobleff, M.D. shares his best practices for ECMO therapy troubleshooting and acute shock with the CentriMag™ Acute Circulatory Support System.
In this episode, Dr. Angela Lorts, Co-Executive Director of the ACTION Learning Network (Advanced Cardiac Therapies Improving Outcomes Network) and Director of the Ventricular Assist Device Program at Cincinnati Children’s Hospital Medical Center will discuss the importance of using a collaborative methodology with quality improvement methods to improve outcomes and define best practices. Dr. Lorts will also share how ACTION has been instrumental to the pediatric heart failure and congenital heart disease patient population.
In this episode, Dr. Goldstein will reflect on how #COVID19 impacted advanced therapies and the future implications for #PatientCare.
Patients with preserved heart failure are notoriously hard to diagnose and manage. In this episode, Dr. Andrew J. Sauer, Chief of Advanced Heart Failure Therapies Division and Associate Professor at the University of Kansas Health System, will discuss how the use of PA pressure monitoring with the CardioMEMS™ HF System can help optimize GDMT and reduce hospitalizations for this hard to manage patient population.
In this episode we discuss the latest in MCS and when advanced therapies should be considered, with Dr. Douglas Horstmanshof, Co-Director, INTEGRIS Advanced Cardiac Care.
Extraordinary advances during the last few decades have allowed people to not only live longer lives, but fuller ones as well. This, however, has come with its own set of challenges as an aging population experiences a host of medical complications uncommon in younger cohorts; one of which is Heart Failure. To keep pace with its increasing prevalence, HF treatment methodology is continuously being optimized while technological innovations are constantly developed and improved upon, year after year.
This podcast represents the views of our guest speaker and do not necessarily represent the views of Abbott. For more information regarding the products featured during this podcast please refer to the approved US indication, important safety information and instructions for use.
For more educational content on Abbott’s life-changing medical device technologies and resources, please visit cardiovascular.abbott.